Zigang Dai, Yixin Yan, Liang Huang. "Polatuzumab vedotin retains potent activity against CD79B mutations: Preclinical and clinical efficacy in diffuse large B-cell lymphoma." Blood, 2025. doi:10.1182/blood-2025-1923